HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response

Table 1

Characteristics of systemic lupus erythematosus (SLE) patients and control subjects.

	SLE	Control
Number	32	24
Sex (female/male)	32/0	24/0
SLEDAI score mean ± s.d.	9.3 ± 3.9	n.a
Anti-dsDNA titre mean ± s.d. (IU/mL)	121.2 ± 86.1	n.a
Patients with nephritis (%)	(17/32) 53%	n.a
Treatment with prednisolone
Patients, number (%)	93.75%	n.a
Treatment with hydroxychloroquine
Patients, no. (%)	87.5%	n.a
Treatment with azathioprine
Patients, no. (%)	0%	n.a

Values are in mean ± standard deviation (s.d.); n.a.: not applicable.